Company Overview of Johnson & Johnson Consumer Inc.
Johnson & Johnson Consumer Inc. produces and markets over-the-counter (OTC) products to families, children, healthcare professionals, and other consumers in the United States and internationally. The company offers TYLENOL product line that consists of products across various pain categories, including arthritis pain, pain with accompanying sleeplessness, and symptoms of cold and flu in the adult and pediatric categories’; BENADRYL, ZYRTEC, and ZYRTEC-D allergy medicines; IMODIUM anti-diarrheal products; and SUDAFED PE nasal decongestants. It provides OTC products for relief of pain and fever, cold and flu, sinus and allergy, digestive health, sleeplessness, hair/scalp care, and children car...
7050 Camp Hill Road
Fort Washington, PA 19034-2210
Key Executives for Johnson & Johnson Consumer Inc.
Johnson & Johnson Consumer Inc. does not have any Key Executives recorded.
Johnson & Johnson Consumer Inc. Key Developments
Phagelux, Inc. Announces Collaboration with Johnson & Johnson for New Antibacterial Solution
Apr 12 17
Phagelux, Inc. announced that it has reached an agreement with Johnson & Johnson Consumer, Inc. to collaborate on the development of one or more skin care products. The deal was facilitated by Johnson & Johnson Innovation. Under the terms of the agreement between the parties, Phagelux will be responsible for developing these products utilizing its patented or patent pending technologies. Johnson & Johnson Consumer, Inc. shall provide specified financial support, access to certain skin care and formulation know-how, and support in protocol strategy and design.
Rest Devices, Inc. Announces Collaboration with Johnson & Johnson Innovation to Develop the First Personalized Baby Sleep Coaching System
Jan 5 17
Rest Devices, Inc. announced a collaboration with Johnson & Johnson Consumer Inc. to develop the first smart, personal baby sleep coaching system. The app, called Nod, will be unveiled at the Consumer Electronics Show (CES) in Las Vegas. While the app will not be fully available until early Feb., parents can sign up on the site www.nodtosleep.com to be part of the upcoming beta program. The collaboration was facilitated by Johnson & Johnson Innovation. Around the world, improving baby sleep is a leading concern for parents. Rest Devices, Inc., through the Mimo Baby wearable monitor, and Johnson & Johnson Consumer Inc., through its JOHNSON'S® BEDTIME® Baby Sleep App, have each studied hundreds of thousands of baby sleep patterns. By combining expert coaching and analytics in one app, the collaboration intends to provide parents with an advanced sleep coaching system that helps parents get their babies to sleep better. Nod will first learn parents' goals, behaviors, and routines for their baby's sleep, then will create customized sleep advice for each baby based on clinically-validated behavioral techniques developed by pediatric sleep experts including Jodi Mindell, Ph.D. Nod will launch early Feb. on iOS and Android devices.
Xycrobe Therapeutics Signs Research Agreement with Johnson & Johnson
Aug 18 16
Xycrobe Therapeutics has signed a research agreement with United States-based Johnson & Johnson Consumer. The partnership is aimed at concentrating on further understanding applications of Xycrobe's platform technology developed for the treatment of inflammatory skin diseases. It is intended to provide both firms with information on how the Xycrobe technology is likely to be best applied to future therapeutic and commercial applications.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|